A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06533644 · RECRUITING
Trial details
- NCT number
- NCT06533644
- Sponsor
- Syncromune, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2028-04-14
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.